Charles River Laboratories International Inc

詳細情報 Charles River Laboratories International Inc 企業名

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

企業情報

企業コードCRL

会社名Charles River Laboratories International Inc

上場日Jun 23, 2000

最高経営責任者「CEO」Mr James C. Foster

従業員数18600

証券種類Ordinary Share

決算期末Jun 23

本社所在地251 Ballardvale St

都市WILMINGTON

証券取引所NYSE Consolidated

国United States of America

郵便番号01887

電話番号17812226000

ウェブサイトhttps://www.criver.com/

企業コードCRL

上場日Jun 23, 2000

最高経営責任者「CEO」Mr James C. Foster

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

13.28K

-2.92%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.96K

+31.35%

Ms. Reshema Kemps-Polanco

Independent Director

2.59K

+155.42%

Dr. Craig B. Thompson, M.D.

Independent Director

2.41K

+64.49%

Mr. Abraham N. (Abe) Ceesay

Independent Director

946.00

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

13.28K

-2.92%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

事業別USD

会社名

収益

比率

DSA

592.61M

60.21%

RMS

213.07M

21.65%

Manufacturing

178.49M

18.14%

地域別USD

会社名

収益

比率

United States

536.96M

54.56%

Europe

263.25M

26.75%

Canada

125.35M

12.74%

Asia Pacific (Region)

41.94M

4.26%

Other

16.67M

1.69%

事業別

地域別

事業別USD

会社名

収益

比率

DSA

592.61M

60.21%

RMS

213.07M

21.65%

Manufacturing

178.49M

18.14%

株主

更新時刻: 21 hours ago

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

11.79%

Nomura Securities Co., Ltd.

10.31%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.66%

他の

60.01%

株主統計

比率

The Vanguard Group, Inc.

11.79%

Nomura Securities Co., Ltd.

10.31%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.66%

他の

60.01%

種類

株主統計

比率

Investment Advisor

51.01%

Investment Advisor/Hedge Fund

42.93%

Hedge Fund

7.75%

Research Firm

7.04%

Pension Fund

1.78%

Bank and Trust

1.36%

Sovereign Wealth Fund

1.10%

Individual Investor

1.05%

Insurance Company

0.08%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

1399

56.14M

114.06%

-4.38M

2025Q1

1435

55.38M

112.72%

-5.93M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

2023Q1

1431

52.72M

103.01%

-2.79M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

6.09M

12.41%

-39.84K

-0.65%

Mar 31, 2025

Nomura Securities Co., Ltd.

601.62K

1.22%

+293.81K

+95.46%

Mar 31, 2025

Wellington Management Company, LLP

4.29M

8.72%

+208.59K

+5.12%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.91M

5.92%

-42.75K

-1.45%

Mar 31, 2025

Allspring Global Investments, LLC

1.77M

3.61%

-33.40K

-1.85%

Mar 31, 2025

State Street Global Advisors (US)

1.90M

3.87%

-278.81K

-12.78%

Mar 31, 2025

Ariel Investments, LLC

1.10M

2.24%

+33.45K

+3.13%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.26M

2.57%

+30.45K

+2.47%

Mar 31, 2025

Impactive Capital LP

1.21M

2.47%

+9.20K

+0.77%

Mar 31, 2025

Invesco Capital Management LLC

981.66K

2%

+78.23K

+8.66%

Mar 31, 2025

詳細を見る

156.580USD

Charles River Laboratories International Inc

156.580

概要

企業名

金融